Skip to main content
Cisen Pharmaceutical Co.,Ltd. logo

Cisen Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 603367 ISIN · CNE100002VG4 LEI · 836800T7RRJXURVHYS35 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,110 across all filing types
Latest filing 2025-06-04 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 603367

About Cisen Pharmaceutical Co.,Ltd.

https://www.cisen-pharma.com/

Cisen Pharmaceutical Co.,Ltd. is a comprehensive enterprise dedicated to the research, development, production, and marketing of a diverse range of medicinal products. The company specializes in the manufacture of large-volume injections, small-volume injections, and solid oral dosage forms, including tablets and capsules. Its product portfolio addresses critical therapeutic areas such as parenteral nutrition, anti-infectives, cardiovascular health, and anesthesia. Cisen Pharmaceutical maintains an integrated value chain, producing both active pharmaceutical ingredients (APIs) and finished formulations. The organization emphasizes technological innovation and stringent quality management systems to ensure the efficacy and safety of its medical solutions. By leveraging advanced manufacturing capabilities and a robust distribution network, the company provides essential healthcare products to clinical institutions and medical providers.

Recent filings

Filing Released Lang Actions
辰欣药业股份有限公司关于持股5%以上股东减持股份计划期限届满暨减持股份结果公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the shareholder's initial holdings, the planned reduction, the actual shares reduced, and confirms the completion of the plan. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is not a full financial report, earnings release, or regulatory filing but a specific announcement about shareholding changes.
2025-06-04 Chinese
简式权益变动报告书（韩延振）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the changes in shareholding by an individual named 韩延振 and his related parties, including the number of shares held before and after the change, the method of share reduction (concentrated bidding and block trades), and the legal compliance statements. The document includes detailed disclosures about shareholding percentages, dates of transactions, and declarations of no other share transactions in the past six months. This type of document corresponds to a notification of changes in significant share ownership levels, which matches the definition of a Major Shareholding Notification (Code: MRQ). The document is not an announcement of a report publication, nor is it a full financial report or management information. It is a regulatory disclosure specifically about shareholding changes.
2025-06-04 Chinese
山东国曜琴岛（济南）律师事务所关于辰欣药业股份有限公司2024年年度股东大会的法律意见书
Regulatory Filings
2025-05-20 Chinese
辰欣药业股份有限公司2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2024 Annual General Meeting Resolution Announcement" for the company 辰欣药业股份有限公司. It details the date and location of the AGM, attendance, voting results on various proposals including the 2024 annual report, financial statements, profit distribution, remuneration plans, and appointment of auditors. The document includes detailed voting results and legal opinions confirming the validity of the meeting and resolutions. This is a formal announcement of the resolutions passed at the Annual General Meeting, including voting outcomes, rather than the full annual report or financial statements themselves. The document length is 4249 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-20 Chinese
辰欣药业股份有限公司关于参加2025年山东辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (535 characters) about the company's participation in an online investor reception day event organized by regulatory and industry bodies. It mentions interaction with investors regarding the 2024 annual performance, governance, strategy, and operations, but does not contain any actual financial data or detailed report content. It is an announcement of an event rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2025-05-12 Chinese
辰欣药业股份有限公司关于2024年度暨2025年第一季度暨现金分红业绩说明会召开情况的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the holding of a performance briefing meeting (业绩说明会) for the 2024 annual results, 2025 first quarter, and cash dividend. It includes details about the meeting date, participants, investor Q&A, and dividend policy discussion. The document does not contain actual financial statements or detailed financial data but rather a summary of the meeting and responses to investor questions. The document length is only 2164 characters, which is quite short and consistent with an announcement rather than a full report. It also references that the detailed information can be found on the Shanghai Stock Exchange website. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an announcement of a performance briefing meeting and dividend information, not the full earnings release or annual report itself.
2025-05-12 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.